FDA approves rival to AbbVie and Novartis drugs
To view this email as a web page, click here

Today's Rundown

Featured Story

Roche lands approval to slash Gazyvaro infusion time in EU, bringing treatment in line with MabThera

Roche has cleared a barrier to the use of Gazyvaro over biosimilar copies of its collapsing blockbuster MabThera. Gazyvaro, known as Gazyva in the U.S., is now cleared for use over the same accelerated 90-minute infusion time as MabThera in follicular lymphoma patients in the EU.

read more

Top Stories

Russian team gets green light to trial nasal COVID-19 vaccine but lacks funding to start study

Russia has joined the ranks of COVID-19 vaccine developers exploring nasal delivery. Having originally developed Sputnik V for intramuscular administration, Russian researchers are now set to study the effects of giving two doses to volunteers via nasal delivery—if they can get funding for the trial.

read more

Oyster Point, with AbbVie and Novartis in its sights, wins first FDA approval for nasal spray to treat dry eye disease

Oyster Point Pharma’s bet that the path to a better dry eye disease treatment goes through the nose has come good, with the FDA approving its Tyrvaya for use in a broad population of patients.

read more

Corium, bouncing back from FDA rejection, snags PDUFA date for weekly Alzheimer's patch

Corium is having another crack at getting its weekly patch treatment for Alzheimer’s disease to market, securing a March PDUFA date a little more than one year after the FDA rejected its first try.

read more

Medtronic to leap ahead in diabetes race with $300M Triple Jump purchase: report

Amid back-to-back expansions of two Class I recalls pertaining to the MiniMed insulin pump technology it acquired two decades ago, Medtronic is reportedly eyeing a purchase of another insulin pump maker.

read more

Resources

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

Research: eTMF Implementation Quick Guide

Check out the eTMF Implementation Quick Guide to see a checklist TMF experts developed to help you reduce risks, maintain compliance, and establish effective processes in your eTMF.

Whitepaper: Modernizing Key Clinical Trial Processes with Artificial Intelligence

This whitepaper addresses where AI can make the biggest impact in clinical trials.

Free Infographic: Identifying Opportunities for Biotech Scale-Up

Looking to accelerate your biotech company, but not sure where to start?

Report: New research indicates an accelerated shift to decentralized clinical trials

New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19.

Whitepaper: Transform LIMS Data into Action-Ready Insights with Advanced Analytics

Shift from data collection to data science. Add advanced analytics to your lab informatics platform to yield valuable, action-ready insights from LIMS and other data.

Whitepaper: Clinical trial simulation: Advanced modeling techniques enable data-driven supply chain planning

Integrate supply chain simulation into your early clinical trial planning to minimize risk in an uncertain supply chain environment, improve supply chain outcomes, and help streamline time-to-market for innovative therapies.

Whitepaper: Big Challenges for Small Sponsors: Competition in Oncology Research

Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles.

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Content Hub: Remarque Systems Resource Hub

Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. 

Events